We have studied the effect of WIN 55,212-2 (a psychoactive cannabinoid agon
ist), cannabinol (a non-psychoactive cannabinoid agonist), SR141716A, a can
nabinoid CB1 antagonist, and SR144528, a cannabinoid CB2 antagonist, on gas
tric emptying in the rat. WIN 55,212-2 (0.1-5 mg/kg, i.p.) and cannabinol (
0.1-25 mg/kg, i.p.) dose-dependently delayed gastric emptying while SR14171
6A (1 mg/kg and 5 mg/kg) and SR144528 (1 mg/kg) were without effect. SR1417
16A (1 mg/kg), but not SR144528 (1 mg/kg), counteracted the inhibitory effe
ct of the two cannabinoid agonists. These results suggest that cannabinoid
agonists delay gastric emptying through activation of cannabinoid CB1 recep
tors, while the endogenous cannabinoid system does not seem to modulate gas
tric motility.